Because these two specific proteins are involved in the mechanisms by which RKIP inhibits GC development, HSP90 and 14-3-3ε proteins can consider as early-stage biomarkers and targets for therapeutic strategies to treat GC. The gene discussed is PEBP1; the disease is gastric cancer.